Genpact CEO Suggests AI May Reduce IT Workload and Employment Growth Fanatics Secures FIFA Collectibles License Faces Scrutiny Over Market Dominance Alibaba Unveils NextGeneration Zhenwu AI Chip and Large Language Model to Bolster Cloud and AI Ambitions Dow Surges 600 Points SP 500 and Nasdaq Rally as Oil Declines and Bond Yields Retreat Ahead of Nvidia Earnings Equity Residential Emerges as a Leading Residential REIT Amid Resilient Rental Demand South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest OCSL Q1 2026 Earnings EPS Surpasses Estimates as Portfolio Remains Resilient CISS Q3 2025 Earnings Loss Per Share of 058 as Shipping Headwinds Persist Stock Declines 339 MBIN Q1 2026 Earnings EPS Beat of 502 Surprises Analysts Yet Stock Declines Pulmonx Corporation LUNG Q1 2026 Earnings NarrowerThanExpected Loss Keeps Sentiment Positive VBNK Q1 2026 Earnings VersaBank Posts BottomLine Miss as Interest Income Pressures Persist IBOC Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement Focus Universal Inc FCUV Faces Selling Pressure Tests Key Support at 075 Quanex Building Products NX Surges Over 3 as Housing Sector Sentiment Improves Linkage Global Inc LGCB Consolidates Near Key Support Is a Breakout Brewing Cosmos Health COSM Slips to 026 Testing Key Support Amid Downside Pressure PCAPW Plunges 17 as Warrants Test Support at 028 Argan Inc AGX Q1 2026 Earnings EPS Surges 737 Above Estimates Shares Climb Nearly 2 Nextpower Inc NXT Q1 2026 Earnings EPS Beats Estimates by 1316 Stock Jumps 78 BioAge Labs Q1 2026 Earnings EPS Beat on Lower Loss PreRevenue Stage Continues CVGI Q1 2026 Earnings EPS Beat Delivers Positive Surprise Amid Revenue Disclosures TERN Q4 2025 Earnings Narrower Than Expected Loss as Pipeline Progress Continues L3Harris Q1 2026 Earnings EPS Beat Drives Positive Market Response Despite Limited Revenue Disclosure Metas New Forum App Pressures Reddit Shares Drop Nearly 6 Uranium Royalty Corp UROY Q1 2026 Earnings EPS Turns Positive Topping Estimates by 199 Stock Slips 3 Relmada Therapeutics RLMD Edges Higher as Stock Holds Above Key Support